Commentary: Josh Hardy: An unanswered call

Almost a year has passed since an extraordinary campaign saved the life of Josh Hardy and started a public discussion about the roles and responsibilities of drug companies and government to provide compassionate access to promising, unapproved therapies.

The good news is that Josh has turned eight and is healthy. ...